Tipiracil

Liothyronine Sodium is indicated for the treatment of Patients with hypothyroidism of any etiology.

Biophore's Liothyronine Sodium: US DMF filed, Completeness Assessment done; CEP Filed

Methazolamide Anti Coagulant indicated for the treatment of ocular conditions.
Biophore's Methazolamide: 

Nadolol is an Antihypertensive agent indicated for the treatment of long-term management of patients with angina pectoris.


Biophore's Nadolol: Lab development complete. Tech pack available. Validations under progress. DMF by Q3, 2016.

Palbociclib is an Cyclin-Dependent Kinase Inhibitor indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2. 

Sincalide is an Diagnostic Agent indicated To stimulate gallbladder, pancreatic secretion, to accelerate the transit of a barium meal through the small bowel.


Biophore's Sincalide: API Developed, Validations Planned in Q3 2016, DMF to be filed in Q1 2017.

Zofenopril is an Antihypertensive agent.

Biophore's Zofenopril: USFDA approved manufacturing facility, US DMF Filed  [ # 026446 ].

Trifluridine is an Antiviral agent indicated for the treatment of of primary kerato conjunctivitis and recurrent epithelial keratitis.

DOTA is an Chelating agent

Biophore's DOTA:   All impurities below 0.07 (% w/w), Stringent control on sodium and chloride, Stable at room temperature, Commercialized product for Europe.

DTPA is an Chelating agent

Biophore's DTPA: Stringent control on Iron content,  All impurities below 0.01

Trientinen is indicated for the treatment of  patients with Wilson's disease who are intolerant of penicillamine.

Biophore's Trientine: DMF Filed

Aviptadil

Benserazide

Biophore India Pharmaceuticals Pvt Ltd. at CPHI BCN 2023